Regeneron Pharmaceuticals, Inc. (REGN): Share Repurchases
$3.44B
Year ended 2025-12-31
$3.30B
Trailing 12 months to 2026-06-30
+18.2%
3-year compound annual growth
-10.1%
5-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.44B | +32.1% | 2026-02-04, From 2025-01-01 |
| 2024-12-31 | $2.60B | +16.5% | 2026-02-04, From 2024-01-01 |
| 2023-12-31 | $2.23B | +7.3% | 2026-02-04, From 2023-01-01 |
| 2022-12-31 | $2.08B | +26.6% | 2025-02-05, From 2022-01-01 |
| 2021-12-31 | $1.65B | -71.9% | 2024-02-05, From 2021-01-01 |
| 2020-12-31 | $5.85B | n/m | 2023-02-06, From 2020-01-01 |
| 2019-12-31 | $275.90M | n/m | 2022-02-07, From 2019-01-01 |
| 2018-12-31 | $4.40M | n/a | 2021-02-08, From 2018-01-01 |
| 2017-12-31 | $0 | n/a | 2020-02-07, From 2017-01-01 |
| 2016-12-31 | $0 | n/a | 2019-02-07, From 2016-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $3.44B | +32.1% |
| Viatris Inc (VTRS) | 2025-12-31 | $500.50M | +100.2% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $2.02B | +71.4% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $3.23B | +74.1% |
| Abbott Laboratories (ABT) | 2025-12-31 | $893.00M | -31.0% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $0 | n/a |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $125.02M | -59.9% |
| AbbVie Inc. (ABBV) | 2025-12-31 | $980.00M | -42.6% |
| Pfizer Inc (PFE) | 2024-12-31 | $0 | n/a |
Compare REGN, VTRS, VRTX, ZTS side by side · Screen every company in Pharmaceutical Preparations ↗